Picchianti-Diamanti, A.; Navarra, A.; Aiello, A.; Laganà , B.; Cuzzi, G.; Salmi, A.; Vanini, V.; Maggi, F.; Meschi, S.; Matusali, G.;
et al. Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine. Vaccines 2023, 11, 1684.
https://doi.org/10.3390/vaccines11111684
AMA Style
Picchianti-Diamanti A, Navarra A, Aiello A, Laganà B, Cuzzi G, Salmi A, Vanini V, Maggi F, Meschi S, Matusali G,
et al. Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine. Vaccines. 2023; 11(11):1684.
https://doi.org/10.3390/vaccines11111684
Chicago/Turabian Style
Picchianti-Diamanti, Andrea, Assunta Navarra, Alessandra Aiello, Bruno Laganà , Gilda Cuzzi, Andrea Salmi, Valentina Vanini, Fabrizio Maggi, Silvia Meschi, Giulia Matusali,
and et al. 2023. "Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine" Vaccines 11, no. 11: 1684.
https://doi.org/10.3390/vaccines11111684
APA Style
Picchianti-Diamanti, A., Navarra, A., Aiello, A., Laganà , B., Cuzzi, G., Salmi, A., Vanini, V., Maggi, F., Meschi, S., Matusali, G., Notari, S., Agrati, C., Salemi, S., Di Rosa, R., Passarini, D., Di Gioia, V., Sesti, G., Conti, F., Spinelli, F. R.,
... Goletti, D.
(2023). Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine. Vaccines, 11(11), 1684.
https://doi.org/10.3390/vaccines11111684
